286 related articles for article (PubMed ID: 33785874)
41. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
42. Serrated pathway in colorectal carcinogenesis.
Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
[TBL] [Abstract][Full Text] [Related]
43. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
44. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
45. Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors.
Shenoy AK; Fisher RC; Butterworth EA; Pi L; Chang LJ; Appelman HD; Chang M; Scott EW; Huang EH
Cancer Res; 2012 Oct; 72(19):5091-100. PubMed ID: 22902411
[TBL] [Abstract][Full Text] [Related]
46. Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition.
Aceto GM; Catalano T; Curia MC
Biomed Res Int; 2020; 2020():1726309. PubMed ID: 32258104
[TBL] [Abstract][Full Text] [Related]
47. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
48. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
[TBL] [Abstract][Full Text] [Related]
49. Critical review of the evidence on 5-aminosalicilate for chemoprevention of colorectal cancer in ulcerative colitis: a methodological question.
Margagnoni G; Pagnini C; Menasci F; Festa S; Delle Fave G
Curr Clin Pharmacol; 2014 Feb; 9(1):84-90. PubMed ID: 24218994
[TBL] [Abstract][Full Text] [Related]
50. WNT/β-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
Urushibara S; Tsubota T; Asai R; Azumi J; Ashida K; Fujiwara Y; Shiota G
Anticancer Res; 2017 Aug; 37(8):4085-4091. PubMed ID: 28739692
[TBL] [Abstract][Full Text] [Related]
51. Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells.
Parenti S; Ferrarini F; Zini R; Montanari M; Losi L; Canovi B; Ferrari S; Grande A
Aliment Pharmacol Ther; 2010 Jan; 31(1):108-19. PubMed ID: 19785626
[TBL] [Abstract][Full Text] [Related]
52. Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?
Khan AA
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2199-2207. PubMed ID: 34115239
[TBL] [Abstract][Full Text] [Related]
53. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
[TBL] [Abstract][Full Text] [Related]
54. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
55. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
[TBL] [Abstract][Full Text] [Related]
56. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
[TBL] [Abstract][Full Text] [Related]
57. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
Fu X; Li L; Peng Y
J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
[TBL] [Abstract][Full Text] [Related]
58. DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid.
MacFie TS; Poulsom R; Parker A; Warnes G; Boitsova T; Nijhuis A; Suraweera N; Poehlmann A; Szary J; Feakins R; Jeffery R; Harper RW; Jubb AM; Lindsay JO; Silver A
Inflamm Bowel Dis; 2014 Mar; 20(3):514-24. PubMed ID: 24492313
[TBL] [Abstract][Full Text] [Related]
59. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
Igder S; Mohammadiasl J; Mokarram P
Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
[TBL] [Abstract][Full Text] [Related]
60. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
